Cargando…

Association Plasma Aβ42 Levels with Alzheimer’s Disease and Its Influencing Factors in Chinese Elderly Population

BACKGROUND AND PURPOSE: Intracerebral Aβ protein deposition is an important pathological mechanism of Alzheimer’s disease (AD) and is one of the indicators of early diagnosis of AD. However, invasive lumbar puncture and Aβ PET are difficult to perform in primary units, resulting delays in early diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yue, Wang, Zhiqiang, Yin, Jiajun, Yang, Bixiu, Fan, Jie, Cheng, Zaohuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420413/
https://www.ncbi.nlm.nih.gov/pubmed/36043117
http://dx.doi.org/10.2147/NDT.S374722
_version_ 1784777383599931392
author Wu, Yue
Wang, Zhiqiang
Yin, Jiajun
Yang, Bixiu
Fan, Jie
Cheng, Zaohuo
author_facet Wu, Yue
Wang, Zhiqiang
Yin, Jiajun
Yang, Bixiu
Fan, Jie
Cheng, Zaohuo
author_sort Wu, Yue
collection PubMed
description BACKGROUND AND PURPOSE: Intracerebral Aβ protein deposition is an important pathological mechanism of Alzheimer’s disease (AD) and is one of the indicators of early diagnosis of AD. However, invasive lumbar puncture and Aβ PET are difficult to perform in primary units, resulting delays in early diagnosis of AD. In recent years, it has been found that plasma Aβ can reflect the pathological state of AD in early stage, but the results are not consistent. The objective of this study was to explore the association between plasma Aβ42 levels and AD cognitive impairment and its influencing factors in Chinese elderly population, so as to provide guidance for the clinical application of plasma Aβ42 as a blood biomarker of AD. METHODS: This is a cross-sectional study based on the community population. Plasma samples were collected from 604 healthy controls (HC), 508 mild cognitive impairment (MCI) and 202 dementia with Alzheimer’s type (DAT) patients from three cities. We analyzed the correlation between plasma Aβ42 levels and cognitive function and the influence of confounding factors on the relationship between plasma Aβ42 levels and AD. The independent influencing factors of plasma Aβ42 levels were determined by covariance and linear regression analysis. RESULTS: Our results suggest that there is a special linear relationship between plasma Aβ42 and cognitive impairment of AD in Chinese elderly population, with Aβ42 levels slightly decreased in early AD and significantly increased in moderate-to-severe AD (P<0.01). There are many factors influencing the association between plasma Aβ42 levels and AD cognitive impairment, and sample source, gender and BMI are independent influencing factors of plasma Aβ42. CONCLUSION: This indentifies that plasma Aβ42 may be a peripheral biomarker for AD screening in Chinese elderly population, but it is necessary to establish standardized detection methods and establish different demarcation criteria for various influencing factors.
format Online
Article
Text
id pubmed-9420413
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-94204132022-08-29 Association Plasma Aβ42 Levels with Alzheimer’s Disease and Its Influencing Factors in Chinese Elderly Population Wu, Yue Wang, Zhiqiang Yin, Jiajun Yang, Bixiu Fan, Jie Cheng, Zaohuo Neuropsychiatr Dis Treat Original Research BACKGROUND AND PURPOSE: Intracerebral Aβ protein deposition is an important pathological mechanism of Alzheimer’s disease (AD) and is one of the indicators of early diagnosis of AD. However, invasive lumbar puncture and Aβ PET are difficult to perform in primary units, resulting delays in early diagnosis of AD. In recent years, it has been found that plasma Aβ can reflect the pathological state of AD in early stage, but the results are not consistent. The objective of this study was to explore the association between plasma Aβ42 levels and AD cognitive impairment and its influencing factors in Chinese elderly population, so as to provide guidance for the clinical application of plasma Aβ42 as a blood biomarker of AD. METHODS: This is a cross-sectional study based on the community population. Plasma samples were collected from 604 healthy controls (HC), 508 mild cognitive impairment (MCI) and 202 dementia with Alzheimer’s type (DAT) patients from three cities. We analyzed the correlation between plasma Aβ42 levels and cognitive function and the influence of confounding factors on the relationship between plasma Aβ42 levels and AD. The independent influencing factors of plasma Aβ42 levels were determined by covariance and linear regression analysis. RESULTS: Our results suggest that there is a special linear relationship between plasma Aβ42 and cognitive impairment of AD in Chinese elderly population, with Aβ42 levels slightly decreased in early AD and significantly increased in moderate-to-severe AD (P<0.01). There are many factors influencing the association between plasma Aβ42 levels and AD cognitive impairment, and sample source, gender and BMI are independent influencing factors of plasma Aβ42. CONCLUSION: This indentifies that plasma Aβ42 may be a peripheral biomarker for AD screening in Chinese elderly population, but it is necessary to establish standardized detection methods and establish different demarcation criteria for various influencing factors. Dove 2022-08-24 /pmc/articles/PMC9420413/ /pubmed/36043117 http://dx.doi.org/10.2147/NDT.S374722 Text en © 2022 Wu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wu, Yue
Wang, Zhiqiang
Yin, Jiajun
Yang, Bixiu
Fan, Jie
Cheng, Zaohuo
Association Plasma Aβ42 Levels with Alzheimer’s Disease and Its Influencing Factors in Chinese Elderly Population
title Association Plasma Aβ42 Levels with Alzheimer’s Disease and Its Influencing Factors in Chinese Elderly Population
title_full Association Plasma Aβ42 Levels with Alzheimer’s Disease and Its Influencing Factors in Chinese Elderly Population
title_fullStr Association Plasma Aβ42 Levels with Alzheimer’s Disease and Its Influencing Factors in Chinese Elderly Population
title_full_unstemmed Association Plasma Aβ42 Levels with Alzheimer’s Disease and Its Influencing Factors in Chinese Elderly Population
title_short Association Plasma Aβ42 Levels with Alzheimer’s Disease and Its Influencing Factors in Chinese Elderly Population
title_sort association plasma aβ42 levels with alzheimer’s disease and its influencing factors in chinese elderly population
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420413/
https://www.ncbi.nlm.nih.gov/pubmed/36043117
http://dx.doi.org/10.2147/NDT.S374722
work_keys_str_mv AT wuyue associationplasmaab42levelswithalzheimersdiseaseanditsinfluencingfactorsinchineseelderlypopulation
AT wangzhiqiang associationplasmaab42levelswithalzheimersdiseaseanditsinfluencingfactorsinchineseelderlypopulation
AT yinjiajun associationplasmaab42levelswithalzheimersdiseaseanditsinfluencingfactorsinchineseelderlypopulation
AT yangbixiu associationplasmaab42levelswithalzheimersdiseaseanditsinfluencingfactorsinchineseelderlypopulation
AT fanjie associationplasmaab42levelswithalzheimersdiseaseanditsinfluencingfactorsinchineseelderlypopulation
AT chengzaohuo associationplasmaab42levelswithalzheimersdiseaseanditsinfluencingfactorsinchineseelderlypopulation